Moving Metabolism to Make Inroads in a Model of Mitochondrial Epilepsy. Issue 6 (November 2019)
- Record Type:
- Journal Article
- Title:
- Moving Metabolism to Make Inroads in a Model of Mitochondrial Epilepsy. Issue 6 (November 2019)
- Main Title:
- Moving Metabolism to Make Inroads in a Model of Mitochondrial Epilepsy
- Authors:
- Lyman, Kyle A.
Chetkovich, Dane M. - Abstract:
- Brain Metabolism Modulates Neuronal Excitability in a Mouse Model of Pyruvate Dehydrogenase Deficiency Jakkamsetti V, Marin-Valencia I, Ma Q, Good LB, Terrill T, Raiasekaran K, Pichumani K, Khemtong C, Hooshyar MA, Sundarrajan C, Patel MS, Bachoo RM, Malloy CR, Pascual JM. Sci Transl Med . 2019;11(480). pii: eaan0457. doi:10.1126/scitranslmed.aan0457. Glucose is the ultimate substrate for most brain activities that use carbon, including synthesis of the neurotransmitters glutamate and γ-aminobutyric acid via mitochondrial tricarboxylic acid (TCA) cycle. Brain metabolism and neuronal excitability are thus interdependent. However, the principles that govern their relationship are not always intuitive because heritable defects of brain glucose metabolism are associated with the paradoxical coexistence, in the same individual, of episodic neuronal hyperexcitation (seizures) with reduced basal cerebral electrical activity. One such prototypic disorder is pyruvate dehydrogenase (PDH) deficiency (PDHD). Pyruvate dehydrogenase is central to metabolism because it steers most of the glucose-derived flux into the TCA cycle. To better understand the pathophysiology of PDHD, we generated mice with brain-specific reduced PDH activity that paralleled salient human disease features, including cerebral hypotrophy, decreased amplitude electroencephalogram (EEG), and epilepsy. The mice exhibited reductions in cerebral TCA cycle flux, glutamate content, spontaneous, and electrically evoked inBrain Metabolism Modulates Neuronal Excitability in a Mouse Model of Pyruvate Dehydrogenase Deficiency Jakkamsetti V, Marin-Valencia I, Ma Q, Good LB, Terrill T, Raiasekaran K, Pichumani K, Khemtong C, Hooshyar MA, Sundarrajan C, Patel MS, Bachoo RM, Malloy CR, Pascual JM. Sci Transl Med . 2019;11(480). pii: eaan0457. doi:10.1126/scitranslmed.aan0457. Glucose is the ultimate substrate for most brain activities that use carbon, including synthesis of the neurotransmitters glutamate and γ-aminobutyric acid via mitochondrial tricarboxylic acid (TCA) cycle. Brain metabolism and neuronal excitability are thus interdependent. However, the principles that govern their relationship are not always intuitive because heritable defects of brain glucose metabolism are associated with the paradoxical coexistence, in the same individual, of episodic neuronal hyperexcitation (seizures) with reduced basal cerebral electrical activity. One such prototypic disorder is pyruvate dehydrogenase (PDH) deficiency (PDHD). Pyruvate dehydrogenase is central to metabolism because it steers most of the glucose-derived flux into the TCA cycle. To better understand the pathophysiology of PDHD, we generated mice with brain-specific reduced PDH activity that paralleled salient human disease features, including cerebral hypotrophy, decreased amplitude electroencephalogram (EEG), and epilepsy. The mice exhibited reductions in cerebral TCA cycle flux, glutamate content, spontaneous, and electrically evoked in vivo cortical field potentials and γ EEG oscillation amplitude. Episodic decreases in γ oscillations preceded most epileptiform discharges, facilitating their prediction. Fast-spiking neuron excitability was decreased in brain slices, contributing to in vivo action potential burst prolongation after whisker pad stimulation. These features were partially reversed after systemic administration of acetate, which augmented cerebral TCA cycle flux, glutamate-dependent synaptic transmission, inhibition and γ oscillations, and reduced epileptiform discharge duration. Thus, our results suggest that dysfunctional excitability in PDHD is consequent to reduced oxidative flux, which leads to decreased neuronal activation and impaired inhibition, and can be mitigated by an alternative metabolic substrate. … (more)
- Is Part Of:
- Epilepsy currents. Volume 19:Issue 6(2019)
- Journal:
- Epilepsy currents
- Issue:
- Volume 19:Issue 6(2019)
- Issue Display:
- Volume 19, Issue 6 (2019)
- Year:
- 2019
- Volume:
- 19
- Issue:
- 6
- Issue Sort Value:
- 2019-0019-0006-0000
- Page Start:
- 408
- Page End:
- 410
- Publication Date:
- 2019-11
- Subjects:
- Epilepsy -- Periodicals
616.853005 - Journal URLs:
- http://bibpurl.oclc.org/web/8402 ↗
http://www.aesnet.org/Visitors/Publications/Currents/Index.cfm ↗
http://www.aesnet.org/go/publications/epilepsy-currents ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=epc ↗
https://journals.sagepub.com/home/EPI ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org/journal=1535-7597;screen=info;ECOIP ↗ - DOI:
- 10.1177/1535759719873360 ↗
- Languages:
- English
- ISSNs:
- 1535-7597
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3793.801000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11796.xml